Hempalta Corp.
HEMP.V
TSX
Weiss Ratings | HEMP.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | HEMP.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Good | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | HEMP.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -0.44 | |||
Price History | HEMP.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | -16.67% | |||
60-Day Total Return | -9.09% | |||
90-Day Total Return | 25.00% | |||
Year to Date Total Return | 11.11% | |||
1-Year Total Return | -70.59% | |||
2-Year Total Return | -57.98% | |||
3-Year Total Return | -78.99% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -81.67% | |||
52-Week Low % Change | 57.14% | |||
Price | HEMP.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.30 | |||
52-Week Low Price | $0.04 | |||
52-Week Low Price (Date) | Oct 07, 2024 | |||
52-Week High Price (Date) | Mar 22, 2024 | |||
Valuation | HEMP.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 3.63M | |||
Enterprise Value | 4.60M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.14 | |||
Earnings Per Share Growth | 346.30% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 14.10 | |||
Price/Book (Q) | 2.70 | |||
Enterprise Value/Revenue (TTM) | 12.82 | |||
Price | $0.05 | |||
Enterprise Value/EBITDA (TTM) | -2.66 | |||
Enterprise Value/EBIT | -2.38 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | HEMP.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 91.40M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | HEMP.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 877-622-3354 | |||
Address | 1560 Hastings Crescent SE Calgary, AB T2G 4E1 | |||
Website | www.hempalta.com | |||
Country | Canada | |||
Year Founded | -- | |||
Profitability | HEMP.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -538.31% | |||
Profit Margin | -1,272.69% | |||
Management Effectiveness | HEMP.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -37.36% | |||
Return on Equity | -- | |||
Income Statement | HEMP.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 358.90K | |||
Total Revenue (TTM) | 358.90K | |||
Revenue Per Share | $0.00 | |||
Gross Profit (TTM) | -251.80K | |||
EBITDA (TTM) | -1.73M | |||
EBIT (TTM) | -1.93M | |||
Net Income (TTM) | -4.57M | |||
Net Income Avl. to Common (TTM) | -4.57M | |||
Total Revenue Growth (Q YOY) | -42.79% | |||
Earnings Growth (Q YOY) | 15.47% | |||
EPS Diluted (TTM) | -0.14 | |||
EPS Diluted Growth (Q YOY) | 55.84% | |||
Balance Sheet | HEMP.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 127.00K | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 545.50K | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 1.94M | |||
Current Ratio (Q) | 1.579 | |||
Book Value Per Share (Q) | $0.02 | |||
Total Assets (Q) | 3.19M | |||
Total Current Liabilities (Q) | 345.50K | |||
Total Debt (Q) | 1.10M | |||
Total Liabilities (Q) | 1.25M | |||
Total Common Equity (Q) | 1.94M | |||
Cash Flow | HEMP.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 1.21M | |||
Cash from Financing (TTM) | 323.20K | |||
Net Change in Cash (TTM) | -52.10K | |||
Levered Free Cash Flow (TTM) | -1.48M | |||
Cash from Operations (TTM) | -1.65M | |||